These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11286607)

  • 1. Enteral suspension of nifedipine for neonates. Part 1. Formulation of nifedipine suspension for hospital use.
    Helin-Tanninen M; Naaranlahti T; Kontra K; Wallenius K
    J Clin Pharm Ther; 2001 Feb; 26(1):49-57. PubMed ID: 11286607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension.
    Helin-Tanninen M; Naaranlahti T; Kontra K; Ojanen T
    J Clin Pharm Ther; 2001 Feb; 26(1):59-66. PubMed ID: 11286608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of para-sulfonato-calix[n]arenes on the solubility, chemical stability, and bioavailability of a water insoluble drug nifedipine.
    Yang W; Otto DP; Liebenberg W; de Villiers MM
    Curr Drug Discov Technol; 2008 Jun; 5(2):129-39. PubMed ID: 18673251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.
    Tanno F; Nishiyama Y; Kokubo H; Obara S
    Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of nifedipine in an extemporaneously compounded oral solution.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2003 May; 60(10):1019-22. PubMed ID: 12789873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability.
    Woertz C; Kleinebudde P
    Int J Pharm; 2015 Sep; 493(1-2):134-45. PubMed ID: 26216415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
    Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
    Gohel M; Bariya SH
    Pharm Dev Technol; 2009; 14(6):650-8. PubMed ID: 19883254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
    Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
    Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer.
    Kojima Y; Ohta T; Shiraki K; Takano R; Maeda H; Ogawa Y
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1484-93. PubMed ID: 22670826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P
    Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water soluble cellulose acetate: a versatile polymer for film coating.
    Wheatley TA
    Drug Dev Ind Pharm; 2007 Mar; 33(3):281-90. PubMed ID: 17454061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: in vitro evaluation.
    Zhao L; Wei YM; Yu Y; Zheng WW
    Arch Pharm Res; 2010 Mar; 33(3):443-50. PubMed ID: 20361310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
    Huang J; Wigent RJ; Schwartz JB
    J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of an orodispersible film containing drug nanoparticles.
    Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.
    Khani S; Keyhanfar F; Amani A
    Drug Deliv; 2016 Jul; 23(6):2035-43. PubMed ID: 26406153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.